European Heart Journal
News
04 Jan 2023
Researchers from Osaka University found that dietary supplementation with tricaprin results in coronary artery plaque regression and resolution of symptoms in patients with triglyceride deposit cardiomyovasculopathy, a treatment-resistant form of coronary artery disease. These findings represent a conceptually novel treatment for coronary atherosclerosis that paves the way toward establishing a multi-faceted approach to caring for patients with this condition.